Study: Fasting lowers the likelihood of insulin resistance caused by obesity
(Natural News) People struggling with obesity and its complications could benefit from fasting. A study presented at the recently concluded Digestive Disease Week, an exhibit sponsored by the American Gastroenterological Association and other groups, revealed that a month of fasting can increase levels of proteins that protect against the adverse effects of diets high in added sugar and... (Source: NaturalNews.com)
Source: NaturalNews.com - December 16, 2019 Category: Consumer Health News Source Type: news

Are Changes in Store for Verily ’s Diabetes Joint Venture?
The dynamics of one of Verily Life Science’s high-profile partnerships could be changing soon. During a recent capital markets day presentation, Sanofi’s newly installed CEO, Paul Hudson, announced the company had “over-invested” in Onduo, its diabetes joint venture with Mountainview, CA-based Verily. The company said it would focus on immunology and vaccine businesses and stop its work in cardiovascular and diabetes R&D efforts. The two companies formed Onduo back in 2016, each investing nearly $500 million. At the time, both Verily and Sanofi sai...
Source: MDDI - December 16, 2019 Category: Medical Devices Authors: Omar Ford Tags: Digital Health Source Type: news

#ICYMI On Friday December 13th, the @US_FDA authorized the first interoperable, automated insulin dosing controller designed to allow more choices for patients looking to customize their individual diabetes management device system. Find out more: https://go.usa.gov/xpwh8   pic.twitter.com/Ak0hkN0zoP
#ICYMI On Friday December 13th, the @US_FDA authorized the first interoperable, automated insulin dosing controller designed to allow more choices for patients looking to customize their individual diabetes management device system. Find out more: https://go.usa.gov/xpwh8  pic.twitter.com/Ak0hkN0zoP (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - December 16, 2019 Category: Medical Devices Authors: ( at FDADeviceInfo) Source Type: news

Intense exercise can help restore heart function in Type 2 diabetes patients: Study
(Natural News) Type 2 diabetes is the most common type of diabetes. A report by the Centers for Disease Control and Prevention says that 90 to 95 percent of the 30 million Americans that have diabetes have Type 2 diabetes. This chronic illness is characterized by a resistance to the hormone insulin, which helps the body convert blood sugar into... (Source: NaturalNews.com)
Source: NaturalNews.com - December 14, 2019 Category: Consumer Health News Source Type: news

FDA Approves New Interoperable Insulin Dosing'Controller'FDA Approves New Interoperable Insulin Dosing'Controller '
The Tandem Diabetes Care Control-IQ Technology is the first to allow communication between interoperable pumps and continuous glucose monitors, representing a step forward in closed-loop technology.FDA Approvals (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - December 14, 2019 Category: Endocrinology Tags: Diabetes & Endocrinology News Alert Source Type: news

Type 2 diabetes: Best food to eat at Christmas to lower blood sugar
TYPE 2 diabetes occurs when the body doesn ’t produce enough insulin to function properly or the body’s cells don’t react to insulin. For an individual who has been diagnosed with the condition, being vigilant with one’s diet is crucial. With Christmas around the corner, what are the best foods to eat for a type 2 diabetic at Christm as? (Source: Daily Express - Health)
Source: Daily Express - Health - December 14, 2019 Category: Consumer Health News Source Type: news

Medtech in a Minute: 3M Quits Drug-Delivery, New FDA Commissioner, and More
It's Official, Hahn Will Lead FDA The U.S. Senate voted 72-18 to confirm Stephen Hahn, MD, as the new FDA Commissioner. The news has been well received by industry advocacy groups like AdvaMed and professional societies like the American Heart Association. Hahn is a radiation oncologist who specializes in treating lung cancer and sarcoma.   3M Calls It Quits on Drug Delivery The company plans to sell most of its drug-delivery business to an affiliate of Altaris Capital Partners for $650 million plus a 17% noncontrolling interest...
Source: MDDI - December 13, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

U.S. FDA approves Tandem's predictive insulin pump software
The U.S. Food and Drug Administration on Friday granted approval for Tandem Diabetes Care's software program that uses readings from a continuous glucose monitor to predict and deliver corrective doses of insulin to patients using the company's t:slim X2 insulin pump. (Source: Reuters: Health)
Source: Reuters: Health - December 13, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Breakfast Like a King: Three-Meal Diet Improves Type 2 Diabetes Breakfast Like a King: Three-Meal Diet Improves Type 2 Diabetes
A three-meal diet plan improves glycemic endpoints and leads to weight loss and less insulin use in type 2 diabetes compared with the usual diabetic diet of six small meals a day.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - December 13, 2019 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Compound in kudzu can help treat diabetes
(Natural News) Diabetes mellitus is one of the most challenging health problems in the world today. It is characterized by abnormally high blood sugar levels caused by the body’s inability to produce enough insulin. Insulin is a pancreatic hormone that regulates how the body utilizes or stores glucose from food. The increasing prevalence and mortality rate of diabetes... (Source: NaturalNews.com)
Source: NaturalNews.com - December 12, 2019 Category: Consumer Health News Source Type: news

Docs Debate Insulin vs GLP-1 Agonist as First Injectable for T2D Docs Debate Insulin vs GLP-1 Agonist as First Injectable for T2D
Two experts debated the statement, which arose from the ADA/EASD type 2 diabetes joint consensus statement, that GLP-1 agonists are preferred to insulin as the first-line injectable medication.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - December 12, 2019 Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news

Changing Timing, Frequency of Meals May Help With Diabetes
THURSDAY, Dec. 12, 2019 -- When you eat and how often you eat can make a big impact on your weight and insulin needs if you have type 2 diabetes, new research suggests. The study found that people who ate three meals a day instead of six smaller... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 12, 2019 Category: General Medicine Source Type: news

New research aims to improve oral delivery of insulin
(Wayne State University - Office of the Vice President for Research) With the help of a $1.7 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health, a team of researchers in Wayne State's College of Engineering will explore ways to address the urgent need for a safe and efficient oral delivery technology to enhance treatment of diabetes. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 12, 2019 Category: International Medicine & Public Health Source Type: news

Insulin and your circadian rhythm: Pay attention to meal timing to improve your overall health
(Natural News) When you eat is just as important as what you eat, according to a recent study published in Cell. Researchers from the Medical Research Council and the University of Manchester found that insulin plays a crucial role in communicating the timing of meals to cellular clocks found all over the body. In particular, eating at the “wrong”... (Source: NaturalNews.com)
Source: NaturalNews.com - December 12, 2019 Category: Consumer Health News Source Type: news

Add gooseberries to your diet to keep metabolic syndrome at bay
(Natural News) Eating Indian gooseberries (Phyllanthus emblica) brings many health benefits to metabolism. A recent study indicates that the extract of this fruit can help treat or even prevent metabolic syndrome. Patients with metabolic syndrome suffer from the following cardiovascular-related conditions: Obesity Insulin resistance Atherogenic dyslipidemia Unhealthy blood pressure Prothrombotic state Excessive inflammation The abnormalities in metabolic syndrome... (Source: NaturalNews.com)
Source: NaturalNews.com - December 12, 2019 Category: Consumer Health News Source Type: news

' Diabetes Burnout' Is Real, Here's How to Cope
TUESDAY, Dec. 10, 2019 -- Living with diabetes -- especially if you need insulin to survive -- is a never-ending job that can be life-threatening if done wrong. That constant daily stress can lead to " diabetes burnout, " a new study says. Diabetics... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 10, 2019 Category: General Medicine Source Type: news

Emergency Preparedness With Diabetes: Two Rules Emergency Preparedness With Diabetes: Two Rules
Dr Anne Peters has two plans for making sure life-saving insulin and other necessities for diabetes are at the ready in case of evacuation or emergency.Medscape Diabetes & Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 9, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology Commentary Source Type: news

West Virginians head to Canada to find affordable insulin
A group of West Virginians have gone to Canada to find affordable insulin (Source: ABC News: Health)
Source: ABC News: Health - December 9, 2019 Category: Consumer Health News Tags: Health Source Type: news

As Diabetes Costs Soar, Many Turn to Black Market for Help
MONDAY, Dec. 9, 2019 -- Skyrocketing prices and insurance limits are driving many people with diabetes to seek medications and supplies from an underground supply chain, a new study found. " The cost of insulin, which is required in type 1 diabetes... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 9, 2019 Category: General Medicine Source Type: news

Time-restricted eating improves metabolic syndrome
Limiting food and drink consumption to a 10-hour daily window could improve body composition, blood pressure and cholesterol levels in adults with metabolic syndrome, according to research presented at the World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - December 9, 2019 Category: Endocrinology Source Type: news

High cholesterol may increase insulin release
According to a study published inMolecular and Cellular Endocrinology, high cholesterol may cause production of a metabolite which increases insulin release, potentially leading to weight gain.Speciality Medical Dialogues (Source: Society for Endocrinology)
Source: Society for Endocrinology - December 9, 2019 Category: Endocrinology Source Type: news

Clinical trial to test stem cells against type 1 diabetes
Researchers believe they may help restore normal immune function in adults with type 1 disease with injections of stem cells, enabling the pancreas to produce insulin. (Source: Health News - UPI.com)
Source: Health News - UPI.com - December 6, 2019 Category: Consumer Health News Source Type: news

Gore ’s Interest in Diabetes Continues with New Investment
W.L. Gore & Associates is setting its sights on helping to improve insulin therapy in patients with type 1 diabetes. To do this the Flagstaff, AZ-based company is investing in PhysioLogic Devices, a startup developing an implantable intraperitoneal insulin delivery system. The investment is set to provide supplemental funding to allow Elkton, MD-based PhysioLogic to reduce key challenges associated with implantable micropumps and actuators and enable the startup's development goals for the upcoming years. An essential part of the system that PhysioLogic is developing is an implanted catheter for intraperitoneal insulin...
Source: MDDI - December 6, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Biocon sees a sweet spot with its affordable insulin in US
The biotech firm is also planning to provide its rh-insulin to middle- and low-income countries at less than 10 cents a day. Biocon Biologics is chasing a revenue target of $1 billion in financial year 2021-22. In the previous fiscal year, its revenue had topped $200 million. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 4, 2019 Category: Pharmaceuticals Source Type: news

A common insulin signaling pathway across cancer and diabetes
(Vanderbilt University Medical Center) An oncology researcher has made an unexpected contribution to the understanding of type 2 diabetes. In results published in Science Advances, Patrick Hu, M.D., associate professor of medicine at Vanderbilt University Medical Center, found a protein that modulates a signaling pathway often targeted by cancer therapies is also required for insulin biogenesis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 4, 2019 Category: Cancer & Oncology Source Type: news

Extent of Insulin Rationing in the US Is'Shameful,' Say Experts Extent of Insulin Rationing in the US Is'Shameful,' Say Experts
International survey of patients with type 1 diabetes finds high rates of rationing of insulin use and glucose testing, with two thirds of patients receiving no financial coverage for diabetes supplies.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - December 3, 2019 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

FDA Expands Use of Toujeo to Childhood Diabetes FDA Expands Use of Toujeo to Childhood Diabetes
First approved for US adults in 2015, Toujeo (insulin glargine 300 units/mL injection) may now be used in children as young as 6 years with type 1 or type 2 diabetes.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - December 3, 2019 Category: Endocrinology Tags: Diabetes & Endocrinology News Alert Source Type: news

FDA Expands Use of Toujeo to Childhood Type 1 Diabetes FDA Expands Use of Toujeo to Childhood Type 1 Diabetes
First approved for US adults with type 1 and type 2 diabetes in 2015, Toujeo (insulin glargine 300 units/mL injection) may now be used in children as young as 6 years with type 1 diabetes.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - December 3, 2019 Category: Endocrinology Tags: Diabetes & Endocrinology News Alert Source Type: news

Hypusine biosynthesis in {beta} cells links polyamine metabolism to facultative cellular proliferation to maintain glucose homeostasis
Deoxyhypusine synthase (DHPS) uses the polyamine spermidine to catalyze the hypusine modification of the mRNA translation factor eIF5A and promotes oncogenesis through poorly defined mechanisms. Because germline deletion of Dhps is embryonically lethal, its role in normal postnatal cellular function in vivo remains unknown. We generated a mouse model that enabled the inducible, postnatal deletion of Dhps specifically in postnatal islet β cells, which function to maintain glucose homeostasis. Removal of Dhps did not have an effect under normal physiologic conditions. However, upon development of insulin resistance, whi...
Source: Signal Transduction Knowledge Environment - December 2, 2019 Category: Science Authors: Levasseur, E. M., Yamada, K., Pineros, A. R., Wu, W., Syed, F., Orr, K. S., Anderson-Baucum, E., Mastracci, T. L., Maier, B., Mosley, A. L., Liu, Y., Bernal-Mizrachi, E., Alonso, L. C., Scott, D., Garcia-Ocana, A., Tersey, S. A., Mirmira, R. G. Tags: STKE Research Articles Source Type: news

1 In 5 US Adolescents Now Prediabetic, Study Says
(CNN) — Nearly a quarter of young adults and a fifth of adolescents in the United States have prediabetes, according to a study published Monday in the journal JAMA Pediatrics. Prediabetes — a condition wherein blood sugar levels are elevated, but not high enough to warrant a diagnosis of Type 2 diabetes — was estimated at 18% among adolescents ages 12 to 18, and 24% among young adults ages 19 to 34. Experts say these numbers have risen over the past decade, putting young people at risk of developing Type 2 diabetes, heart disease and other conditions down the line. “Until recently, young children a...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - December 2, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Syndicated CBSN Boston CNN Diabetes Source Type: news

Vitamin D supplementation may help treat type 2 diabetes
According to a study published in theEuropean Journal of Endocrinology, vitamin D supplementation improves insulin sensitivity and beta cell function in individuals at high risk for diabetes or newly diagnosed type 2 diabetes.Speciality Medical Dialogues (Source: Society for Endocrinology)
Source: Society for Endocrinology - December 2, 2019 Category: Endocrinology Source Type: news

Unexpected viral behavior linked to type 1 diabetes in high-risk children
(University of South Florida (USF Health)) New results from the Environmental Determinants of Diabetes in the Young (TEDDY) study show an association between prolonged enterovirus infection and development of autoimmunity to the insulin-producing pancreatic beta-cells that precedes type 1 diabetes. Conversely, adenovirus C infection seems to confer protection from autoimmunity. The international research suggests new therapeutic avenues for prevention in some children. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 2, 2019 Category: Infectious Diseases Source Type: news

Type 2 diabetes warning: A popular activity is dangerously affecting your blood sugar
TYPE 2 diabetes occurs when the body doesn ’t produce enough insulin to function properly or the body’s cells don’t react to insulin. When one is diagnosed with the condition, certain lifestyle choices and diet will need to change in order to better manage the condition. One surprising activity is known to raise blood sugar regulation. What is it? (Source: Daily Express - Health)
Source: Daily Express - Health - December 1, 2019 Category: Consumer Health News Source Type: news

Eating After You Exercise May Provide Added Fat-Burning Benefits
Cyclists who had pedaled on an empty stomach incinerated about twice as much fat as those who had consumed a shake first. (Source: NYT Health)
Source: NYT Health - November 27, 2019 Category: Consumer Health News Authors: Gretchen Reynolds Tags: Exercise Diabetes Fasting Muscles Insulin Weight Source Type: news

Clinical Immunogenicity Considerations for Biosimilar and Interchangeable Insulin Products
Guidance for Industry - Biosimilars (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - November 26, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

The Costly, Life-Disrupting Consequences of Poor Diabetes Care
At least three out of four diabetics do not adequately control the four major factors that increase the risk of serious complications: blood glucose, blood pressure, blood cholesterol and smoking. (Source: NYT Health)
Source: NYT Health - November 25, 2019 Category: Consumer Health News Authors: Jane E. Brody Tags: Diabetes Health Insurance and Managed Care Cholesterol Blood Pressure Sugar Diet and Nutrition Kidneys Insulin Weight Source Type: news

Insulin sensitivity greater in transgender men
Transgender men who have undergone hormone therapy have greater insulin sensitivity, according to a study published inDiabetes Care.Diabetes.co.uk (Source: Society for Endocrinology)
Source: Society for Endocrinology - November 22, 2019 Category: Endocrinology Source Type: news

More than 300 UCLA health care providers treat the homeless at Care Harbor free clinic
For Dr. Patrick Dowling, volunteering at the 2019Care Harbor free clinic for people who are uninsured or who lack access to health care is a sharp break from his norm of treating people at UCLA Medical Center, Santa Monica.This atypical setting on the front lines of health care for the most vulnerable, sometimes results in unorthodox treatments.Dowling and other care givers at the annual clinic held at The Reef in downtown Los Angeles noticed that although the 60-year-old man they were treating said he had given himself insulin prior to his arrival at the clinic, his blood sugar level had fallen too low.Typically, physicia...
Source: UCLA Newsroom: Health Sciences - November 21, 2019 Category: Universities & Medical Training Source Type: news

WHO to Test, Approve Generic Insulin
THURSDAY, Nov. 14, 2019 -- Testing and approval of generic insulin will be conducted by the World Health Organization in an attempt to combat rising prices and shortages of the drug. About half of the 80 million people with diabetes worldwide who... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 14, 2019 Category: Pharmaceuticals Source Type: news

Diabetes Technology Often Priced Out of Reach
THURSDAY, Nov. 14, 2019 -- While the high price of insulin has gotten a lot of attention lately, it's not the only cost issue facing people with diabetes. New technologies designed to improve blood sugar management often cost too much for people to... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 14, 2019 Category: General Medicine Source Type: news

Health Highlights: Nov. 14, 2019
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: WHO to Test, Approve Generic Insulin Testing and approval of generic insulin will be conducted by the World Health Organization in an attempt to... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 14, 2019 Category: General Medicine Source Type: news

Africa: Initiative Aims to Expand Diabetes Treatment
[VOA] On the eve of World Diabetes Day, November 14, the World Health Organization is launching a new initiative it believes will allow greater access to life-saving insulin at lower prices for a greater number of people suffering from diabetes. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 14, 2019 Category: African Health Source Type: news

NTU scientists discover new way to promote insulin production in pre-diabetes phase
(Nanyang Technological University) NTU Singapore scientists have discovered that a type of immune cell known as 'pancreatic islet macrophages' is capable of promoting insulin production during the pre-diabetes phase. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 14, 2019 Category: International Medicine & Public Health Source Type: news

FDA panel votes against Lilly-Boehringer Ingelheim's diabetes drug
Independent experts on an FDA advisory panel on Wednesday voted against the use of an already approved diabetes drug from Eli Lilly and Co and Boehringer Ingelheim as an add-on to insulin therapy in patients with type 1 diabetes. (Source: Reuters: Health)
Source: Reuters: Health - November 14, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

To Drive Down Insulin Prices, W.H.O. Will Certify Generic Versions
About 80 million people with diabetes around the world need the hormone, and half of them can ’t afford it. Creating competition could help, the agency said. (Source: NYT Health)
Source: NYT Health - November 14, 2019 Category: Consumer Health News Authors: Donald G. McNeil Jr. Tags: Diabetes Insulin Prices (Fares, Fees and Rates) Drugs (Pharmaceuticals) Generic Brands and Products World Health Organization Food and Drug Administration Eli Lilly and Company Novo Nordisk A/S Sanofi SA Doctors Without Borders Source Type: news

Wednesday's Daily Brief: UN bid to aid diabetics, Israel-Gaza attacks, climate change in Nepal, Iraq envoy appeal to MPs
A recap of Wednesday’s stories in brief: UN leads plan for insulin supply boosts; ‘No justification’ for Gaza border violence; Iraqis paying ‘unthinkable price’ in protests; $1.35 billion needed for Venezuela crisis; Record flooding affects 100,000 Nigerians. (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - November 13, 2019 Category: International Medicine & Public Health Source Type: news

UN leads bid for cheaper insulin, expanding access for diabetics worldwide
Overly expensive insulin could be a thing of the past – and life-changing news – for millions of diabetics under a plan launched by the World Health Organization (WHO) on Wednesday to diversify production globally, just ahead of World Diabetes Day. (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - November 13, 2019 Category: International Medicine & Public Health Source Type: news

Light-Activated Insulin-Producing Cells May Lead to New Drug-Free Diabetes Treatment
Title: Light-Activated Insulin-Producing Cells May Lead to New Drug-Free Diabetes TreatmentCategory: Health NewsCreated: 11/12/2019 12:00:00 AMLast Editorial Review: 11/13/2019 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - November 13, 2019 Category: Endocrinology Source Type: news

Commonly prescribed anti-inflammatory 'may increase the risk of diabetes'
Prednisolone was given to a group of men in a study led by Sapienza University of Rome. Their blood sugar regulation was impaired as a result. It could lead to insulin resistance. (Source: the Mail online | Health)
Source: the Mail online | Health - November 12, 2019 Category: Consumer Health News Source Type: news

WSU study shows insulin can increase mosquitoes' immunity to West Nile virus
(Washington State University) A discovery by a Washington State University-led research team has the potential to inhibit the spread of West Nile virus as well as Zika and dengue viruses. The researchers demonstrated that mammalian insulin activated an antiviral immunity pathway in mosquitoes, increasing the insects' ability to suppress the viruses. Since mosquito bites are the most common way humans are infected with West Nile, stopping the virus among the insects would protect human health. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 12, 2019 Category: Infectious Diseases Source Type: news